ET
JAZZ icon

Entropy Technologies’s Jazz Pharmaceuticals JAZZ Stock Holding History

Entropy Technologies’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$556K Sell
2,942
-25,521
-90% -$4.46M 0.03% 564
2025
Q4 		$4.84M Buy
+28,463
New +$4.36M 0.26% 111
2024
Q3 		– Sell
-7,394
Closed -$789K – 835
2024
Q2 		$789K Buy
7,394
+3,312
+81% +$364K 0.09% 282
2024
Q1 		$492K Sell
4,082
-2,206
-35% -$270K 0.05% 448
2023
Q4 		$773K Buy
+6,288
New +$785K 0.14% 245

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Entropy Technologies's JAZZ Position: Q1 2026 in Review

Entropy Technologies reduced its Jazz Pharmaceuticals (JAZZ) stake by 90% in Q1 2026, selling an estimated $4.46M and leaving 2,942 shares worth $556K. The position accounts for 0.03% of the portfolio, ranked #564.

Entropy Technologies first reported a position in JAZZ in Q4 2023 and has held it in 5 quarters since. The position peaked at $4.84M in Q4 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Entropy Technologies held 2,942 shares of Jazz Pharmaceuticals worth $556K as of Q1 2026.
  • Entropy Technologies sold 25,521 Jazz Pharmaceuticals shares in Q1 2026, an estimated $4.46M.
  • Jazz Pharmaceuticals made up 0.03% of Entropy Technologies's portfolio in Q1 2026, its #564 holding.
  • Entropy Technologies first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
  • Entropy Technologies's Jazz Pharmaceuticals position peaked at $4.84M in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Entropy Technologies's 13F filing for Q1 2026, filed 14 May 2026.